18+ · Research Use Only · Not for Human Consumption
The recovery stack: why research runs BPC-157 and TB-500 together.
The most requested pairing in the catalogue is two compounds studying two different halves of the tissue repair problem. The logic, the literature, and the pricing.
Two mechanisms, one problem
Tissue repair is not a single process, and the two compounds in this stack are studied for different layers of it. BPC-157, a 15-residue fragment derived from a gastric protein, is investigated in animal models for angiogenic signaling: the formation of new blood supply around damaged tissue, plus effects on tendon and ligament models. TB-500, a fragment of thymosin beta-4, is studied for actin sequestration and cell migration: how repair cells physically move to where they are needed.
Localized signaling on one side, systemic cell mobility on the other. That split is the entire rationale for the pairing, and it is why the two names travel together across the recovery literature. The head-to-head mechanics are compared in more depth in BPC-157 versus TB-500.
How research protocols combine them
To be precise about framing: a stack here means how research protocols combine compounds within a study design, not advice for personal use. In the preclinical literature, combination arms exist because a model dosed against two mechanisms can show effects a single-mechanism arm does not, and because the two compounds' overlapping interest areas, soft tissue, tendon, ligament, make them natural co-subjects. Both are supplied as lyophilized powder and prepared the same way in the lab, with bacteriostatic water, which keeps combined protocols operationally simple.
Each compound also stands alone. BPC-157 has three decades of standalone literature from gastric protection models outward, and TB-500's parent protein has its own research history. Running one is a valid protocol. Running both is simply the configuration the catalogue sees requested most.
Catalogue pricing for the pair
BPC-157 ships as a 20mg vial at ₱2,240, or ₱2,020 on a first order, double the 10mg size most listings carry. TB-500 is a 5mg vial at ₱2,750, or ₱2,480 first order. The smaller vial holds a similar price because the 43-residue TB-500 costs considerably more per milligram to synthesize than the short BPC-157 chain.
Both vials on a first order come to ₱4,500. Both halves of the stack are in stock, ship together in one insulated pack, and dispatch same day across Metro Manila on orders verified before noon.
Supplied for laboratory research use only. Not for human consumption. Nothing on this page is medical advice.
Recovery stack questions
What is the recovery stack?
In research protocols, the recovery stack means running BPC-157 and TB-500 in parallel within one study design. BPC-157 is studied for angiogenic signaling and localized repair, TB-500 for actin regulation and cell migration. Protocols pair them to cover both mechanisms at once.
How much does the BPC-157 and TB-500 pair cost?
BPC-157 20mg is ₱2,240, or ₱2,020 on a first order. TB-500 5mg is ₱2,750, or ₱2,480 first order. Both vials on a first order come to ₱4,500, plus ₱250 for bacteriostatic water if needed.
Can research run BPC-157 alone without TB-500?
Yes. Each compound has its own standalone literature, and BPC-157 alone is the most common starting point in the catalogue. The pairing exists because the mechanisms differ, not because either compound depends on the other.
Is TB-500 in stock right now?
Yes. TB-500 5mg is in stock at ₱2,750, or ₱2,480 on a first order, dispatching same day across Metro Manila alongside BPC-157.